During the past decade, Residence XII conducted 0 clinical trials. In the 10-year time frame, 0 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "Residence XII" #1 collaborator was "National Institute on Drug Abuse (NIDA)" with 1 trials as a collaborator. Other collaborators include -1 different institutions and companies that were collaborators in the rest 1 trials.

According to Clinical.Site data, the most researched conditions in "Residence XII" are "Substance Use Disorder" (1 trials) and "Substance-Related Disorders" (1 trials). Many other conditions were trialed in "Residence XII" in a lesser frequency.

Most popular intervention types in "Residence XII" are "Behavioral" (2 trials). Other intervention types were less common.

The name of intervention was led by "Behavior Therapy" (1 trials) and "Mindful Awareness in Body-oriented Therapy" (1 trials). Other intervention names were less common.

The vast majority of trials in "Residence XII" are 2 trials for "Female" genders.

Currently, there are NaN active trials in "Residence XII". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 2 completed trials in Residence XII, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Residence XII, 1 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 1 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".